Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.77238.70121.1264.8116.13

What is the latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS is -23.77 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-23.77
Mar2024238.70
Mar2023121.12
Mar202264.81
Mar202116.13

How is Core EBITDA Growth of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.77
Negative
Mar2024 238.7
97.08
Mar2023 121.12
86.88
Mar2022 64.81
301.80
Mar2021 16.13 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,317.5 Cr -6% -5.7% 111.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-6%

-5.7%

111.5%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses